Patent

2 stories about Patent
חברת ה תרופות טבע Teva

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer
A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug
default image

Your First Investor Meeting, a Survival Guide

27.09.17|Zachi Zach
Your first meeting with a potential investor is critical because you probably won’t get another chance. Do your homework